Reddit Posts
Altimmune and Viking are the last two companies left for Pharma to FOMO into the Obesity market
Altimmune and Viking are the last two companies left for Pharma to FOMO into the Obesity market
7 Diabetes and Weight Loss Drug Stocks With Big Potential
VIKING therapeutics VKTX trying to go high.. seeing unusual call activities..
VKTX yesterday there was high unusual call activities there must be something nrws, it can spike to the new high..
VKTX lot of unusual call activity(half million twice) today, there must be something, get into this guys..
Viking stock jumps on early-stage data for obesity drug (NASDAQ:VKTX)
I Told You Guys Early On We Were In For A Treat From The Healthcare Sector 📈 Only 2 Stocks With Trading Plans Posted Today In The Chatroom ✌️ $VKTX $BMEA Not 10 - 20 Stocks ❌ Both Stocks Closed Green After Hours Making New Highs ✔️ This Is Why We Have The #1 Chatroom For Breakout Alerts 🚨
I Told You Guys Early On We Were In For A Treat From The Healthcare Sector 📈 Only 2 Stocks With Trading Plans Posted Today In The Chatroom ✌️ $VKTX $BMEA Not 10 - 20 Stocks ❌ Both Stocks Closed Green After Hours Making New Highs ✔️ This Is Why We Have The #1 Chatroom For Breakout Alerts 🚨
$VKTX The Original Trade Alert Before The Trading Plan 7:08 AM 🚨 A Little Early For Most ☀️ ☕️ 3 Trading Plans In Total On This Play Alone Today , $13.88 Entry By Far The Best ✔️
$VKTX The Original Trade Alert Before The Trading Plan 7:08 AM 🚨 A Little Early For Most ☀️ ☕️ 3 Trading Plans In Total On This Play Alone Today , $13.88 Entry By Far The Best
$VKTX Started The Morning Superb 😃 After The Bell We Needed A Gap Fill 😴 Very Low Range With Each Candle 😴 The Price Action Isn’t Bad But The Range Is Very Low 😴 $BMEA $ITCI $OSCR $SPY
$VKTX Started The Morning Superb 😃 After The Bell We Needed A Gap Fill 😴 Very Low Range With Each Candle 😴 The Price Action Isn’t Bad But The Range Is Very Low 😴 $BMEA $ITCI $OSCR $SPY
VKTX$ Viking Therapeutics - Thoughts on this stocks?
VKTX$ Viking Therapeutics - Looking for thoughts/ideas
VKTX is on the rise !! 🛸🛸🛸 support this life changing company 🤔🤔
Mentions
Tech is becoming too crowded on each side, trying to find value elsewhere. My plays for tomorrow: 1) VKTX 63p exp 05/10, 2) XOM 119c exp 04/26, 3) IP (international paper) 35c exp 04/26
VKTX earnings going to fly past LLY weight loss drugs
Anyone following VKTX? Earning today. I have 150 shares and some calls...might get more calls, but after TSM and Tesla chaos I don't like earning days anymore.
Ain’t nobody talking about VKTX and their weight loss drug in here. Earnings today catch your bag
All mine expired 4/19 and I’ll only be playing them for special occasions..NVDA VKTX and DKNG shares are going to take me to the promise land lol
VKTX is primed to take a large chunk of the market share from NVO in the coming year~ish, and it's in a nice pullback right now. They have a fat cutting drug coming that is way more effective than Ozempic.
VKTX dropping before earnings 🤔
Add MRNA and VKTX for some juicy pennants
VKTX hurts bro. I also sold early and missed the boat but not nearly 15k shares worth. Maybe a couple hundred. I’m sorry for your loss.
VKTX yes it had a big run up but is ideal for a buyout ! Weight loss will be a home run world wide market !
$ASMB this just keeps going up last few months, great looking chart $INMD so hated that it becomes a good long. Has a huge cash pile and generating lots more. New chairman soon might generate more shareholder return. $MREO one of the most underrated bios with phase 2 and 3 potential medicines $VKTX GLP1 play, had very good results
I like LLY moderately more (and VKTX) but I think NVO is a decent place to start a position here and add if it goes lower. I've owned all three for a while. CELH is something that I think continues to do well and doesn't have a negative impact from GLP-1. A less talked about consumer packaged goods name that may continue to do well that benefits from GLP-1 is BRBR - people taking GLP-1's need protein and protein shakes are a common topic on r/ozempic.
Thoughts on Novo Nordisk (NVO) at this price? Lowest in a month, and I love the potential of the GLP-1 weight-loss technology. In my own life I know two people on Ozempic, and wouldn't be surprised if almost everyone I know has at least one family member on it now. The potentials of an orally consumable pill form I think are *huge*, and if they can get limit the side-effects at the same time I think they're going to see some nice gains there. They've got competition from LLY and potentially VKTX, but I'd argue NVO has gotten name-brand recognition of 'Ozempic' for life, and I can definitely see people calling competitor's products 'Ozempic' out of habit. I've seen it suggested that CELH (Celsius Holdings Inc.) would actually rise as people took GLP-1 based drugs as people are looking for energy but aren't replacing those calories with food. That's an interesting possibility as well, but I'm not sure if I like CELH at this price. (Though I do think that it's popping up more and more in stores near me, so maybe I should just pick some up.)
>Oral data from VKTX is very compelling. Curious, are you a company insider or a PI? Looks like they only have safety (phase 1) data on the oral.. unsure if that's what you're referencing when you say "very compelling". Without phase 2(+/-b) data, I'm not sure you can even make a stand for efficacy. This is why I ask if you somehow have prelim data.
That doesn’t change the fact that avg joe who wants to lose 17 lbs doesn’t want to deal with needles. Oral data from VKTX is very compelling.
The real play is $VKTX. The only play with good oral medication progress. Nobody wants to prick themselves with a needle if they don’t have to.
Calls on both for Er and holding shares of VKTX
I take Wegovy, but I want to switch to Zepbound because it is the superior product. More weight loss with fewer side effects. LLY is the way to go, but NVO has the much stronger brander name with Ozempic. I own $40k of both, plus $15k of each VKTX and GPCR in case they launch a strong competitor product and get acquired.
I think the semaglutide monopoly ends in 2032, when it goes generic. So they can make tons of cash and charge whatever they want until then. $NVO will have competition from others like $ALT who's latest trial showed better results when it comes to muscle loss. $NVO is great for long term but $ALT is the wildcard play because it's dirt cheap compared to $VKTX.
Resorting to TLRY calls like a true degen because VKTX fucked me so hard
VKTX needs to be fast-tracked… who’s got a contact at the FDA?
Damn VKTX. Really thought it was going to rip some faces off when it got through 80
Come on VKTX it's rip time baby
Come on VKTX give us the breakout here
LFG VKTX. Give me some buyout rumors stat
PFE if you could end my blue balls and just go buy VKTX for $120 a share I'd appreciate it
27 portfolio value 8k - some retail investing experience from 2021. Learned a lot but took a bigger risk than I'd ever take again and stepped back during grad school. Looking at growth and long-term investing. These will not be the same positions in my Roth. Trying to go on the riskier side with a small allocation of funds while hedging with the Mag 7s and semi ETF. Experimenting with 2 very speculative biotech plays (one being VKTX) but I'm also particularly familiar with the science behind both of their niches. AAPL 37% (ETF) SMH 22% AMZN 13% NET 12% NVO 6% VKTX 4% PLTR 2% SOFI 1% And 1% in a biotech play I don't wanna get automoded for It's not a huge portfolio value so I'm skewed towards picks I've done a lot of research on and understand well but would love input on the risk management aspect.
how do i see the oral and NASH data for VKTX?
Zepbound will be the big story this earnings play. Lilly direct is going to severely change distribution, but also likely route it away from cosmetic weight loss people for a while. Other plus to ofc keep in mind are VKTX, NRBO (early stage lottery ticket), and ALT (reduced lean muscle mass loss). Eventually, anything in oral form is going to kick any injector solution’s ass
How does VKTX compare to LLY? It too ran but potential??
already very saturated unless TERN is using a difference molecule with zero side effects, more convenient administration method...etc. something that sets them apart, this will not be a major player in the field VKTX is not solely focused on the obesity drug, they also are a front runner on ground breaking drugs to treat NASH.
Market closed today? Time to get baked and goon baby ​ LAAC, VKTX and short DNUT
They will/should annouse oral dosing move to a phase 2. If it plays out like SC dose, that will progress quickly and can get finished before end of year. It will over enroll due to American fatties wanting free fat loss pills. Readout 1q25. SC dosing moves to phase 3. The public offering gave them the cash to supoort this. Enrollment begins later thus year or early 25 once FDA gives them the go ahead. Again, over enroll much faster than anticipated. Suspect submission to fda in 25 if all the stars align. The new might pump this way up. Approval in 2026? NASH moves to phase 3 later thus year. This gad 2 phase 2 studies for a couple reasons. Most importantly, they didnt have the.money foe a full phase 3 and commercialization. Allowed Madrigal to jump in front of them. Money isnt an issue now. Will move forward later this year. Much longer 52 week study if i recall. Maybe 26 for readout. Possible buyout. Most likely (my opinion) is pfizer. Pfizer recently sold off $3 billion of another holding. VKTX is worth $7B. I suspect this may happen sooner rather than later now that weight loss meds are progressing. Plus, NASH for free and a few other candidates in the pipeline. Bottom line is it will muddle around maybe $75-90 range for the next 4-6 weeks is my guess. Buy closer to $70. Good luck.
Is anyone on VKTX? Like there’s a ton of fat ppl but how much higher can this stock go?
VKTX has been a great stock for investing and trading. I picked up a chunk in the teens and another in the 30s. After the big run up volatility has been wild so I have been trading options on it. I sold a couple of puts at the 75 strike for $11, and then last week I sold the April 5th the 60, 84 strangle for 10.50, closed it a few days later for around 50 percent profit. If you are looking to pick up som shares for the long term consider selling a naked put to lower your cost basis.
Lots of good news from clinical stages and lower interest on the horizon. ALT / VKTX / APGE
Somebody go buy VKTX already. Big boys without Ozempic are all fucked
Merck imma need you to go make an offer on VKTX this weekend
$VKTX will solve cancer and loneliness too. $1000 target
I don’t expect a VKTX-like pop, but just something would be nice.
HOOD, VKTX and RDDT, what do you think?
Right there with you. I started with a portfolio of 25 stocks so I was spreading my money around like an idiot. I put the most in VKTX because my gut told me it was a winner but had I made a serious commitment, it would have been life changing
I just wish I had more $$$ into VKTX back in the day
VKTX - get on the rocket !
VKTX CALLS 
don't sleep on VKTX 
>VKTX I wrote about Ozempic being a massive buy at $70. It started going from $70 to $130 and people called me crazy, despite 70lbs weight loss in 8 months. "investors" were more interested in shaming fat people discovery the cure of obesity and started bitching about thyroid cancer, which thyroids can be removed easily.
$VKTX banga banga bangaaaaa‼️
VKTX heading to the moon today. I’d expect a buyout after these oral efficacy results
VKTX Phase 2 trials have begun. On a personal note, these oral weight loss drugs sound magical. Too bad they didn't exist when I was going through my weight loss journey. :')
VKTX gonna have a really good day today with those oral results. +18% premarket.
VKTX mooning. New results of clinical trial out. Purchase them pre-market while you still can! 😉 Viking Therapeutics Announces Results from Phase 1 Clinical Trial of Oral Tablet Formulation of Dual GLP-1/GIP Receptor Agonist VK2735 https://www.prnewswire.com/news-releases/viking-therapeutics-announces-results-from-phase-1-clinical-trial-of-oral-tablet-formulation-of-dual-glp-1gip-receptor-agonist-vk2735-302098869.html
Nvidia and VKTX! Let’s go!!!
VKTX oral results are out. Apparently they were good, because it's up 8% premarket.
$ALT is still in clinical stage whereas NVO and LLY have a drug on the market now. NVO also has ozempic which has been on the market going on 6+ years with no serious adverse effects. I hope ALT drug works but they are still a long way from production ready. I think NVO and LLY will dominate the market for at least the next 3 years and if they keep pouring money into R&D they might get too far ahead to catch up by these smaller players as they make better versions of their weight loss drugs. So NVO is safer and I would bet big money on it for the next 3-5 years whereas ALT and VKTX are both promising but could flop so invest with caution.
Actually NOVO just had 2 more drugs approved very recently. A doctor friend of mine assured me NOVO is a very safe long term hold. I also added cheaper cousin VKTX to my portfolio. But to OP's question, NOVO all the way.
AAPL and MSFT of course, but the one that has been a pleasant surprise was the shares of VKTX I bought on a whim a couple years ago for $3.31 that are now going for around $70. Wish I’d bought a lot more of those.
They are the best marketing for GLP1 drugs like Ozempic. Calls on ALT and VKTX
VKTX. Viking Therapeutics. Hodling shares from sub $15 to various Call options up to $85. Will eventually be sold to one of Big Pharma to own Glp1 and NASH markets.
I would be worried about fat loss drugs. Keeping an eye on VKTX in that regard.
VKTX is a runner. I underestimated the fatness of this country and being fat sucks almost as bad as exercising so calls
Like VKTX which made me a lot of money. Puts it is then!
I'm almost out of the loop to send the VKTX dd. Can you guys help me get to the 69 karma mark 💀 57/69 (Please let this be the final comment)
Please get me out of this boring ass loop. I spent like 2 hrs writing VKTX DD but my dumbass isn't at 69 karma. Can you help me get there 💀 ☠️ 37/69
Sry for spamming but my dumbass spent 2 hours writing DD for VKTX and I don't got 69 karma. Can you guys help me get out of the loop of sending the same comment 20/69 *
Long time lurker here I got some dd I want to post on VKTX. I hate spamming but can you regards help me get to 69 karma? X2
Long time lurker here I got some dd I want to post on VKTX. I hate spamming but can you regards help me get to 69 karma?
I got some dd I want to share with the community about VKTX. Can you regards help me get to 69 karma pls?
Look at the giant shrek dildos on VKTX 👀
The spreads on these VKTX calls are ridiculous. Shares play
Should have bought in Jan. Just like Ventyx and VTYX and VKTX
What's the play on VKTX? Similar?
> VKTX What is the play on VKTX?
$2k/yr? With listing prices it’s currently at 1k/pax/month. 10mn people will be way down the line I think, and once the bottleneck gets resolved, there’s where the upside comes in. VKTX for speculation would be fun tho fuck DD on that 🤣 I hope they get bought out ngl no way they’re gonna be able to compete with Lilly unless they’re building out plants like literally today
OPRAH (LLY NVO VKTX) VS JENSEN (NVDA + FRIENDS) TONIGHT https://www.reddit.com/r/wallstreetbets/s/CylrGn1BMf PICK YOUR SIDE
agree i also hold VKTX an an expect that to happen But Lily is the NVDA of Phama !